Expert Interview
Second View: Discussing the recent FDA acceptance for Vertex Pharmacuetical's Suzetrigine, an investigational oral, selective NaV1.8 pain signal inhibitor.
Ticker(s): VRTXInstitution: LSU Health Sciences Center
- Assistant Professor of Clinical Anesthesiology at LSU Health Sciences Center
- Affiliated with University Medical Center-New Orleans and Ochsner Medical Center-Kenner
- Manages 10 patients daily with postoperative nausea and vomiting
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
